Equibles does not estimate personal net worth.
Get an email with a short summary when BridgeBio Pharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get BBIO alertsJustin Dole has spoken on 1 earnings call across 1 company, most recently for BridgeBio Pharma, Inc. on October 29, 2026. BridgeBio Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BridgeBio Pharma, Inc. includes Neil Kumar (CEO and Board Member), Charles Homcy (Chairman and Board Member), Brian Stephenson (CFO) and 7 others.
“So first, we do not anticipate that this will impact a review timeline or a label. I think there were a lot of false assertions and assumptions in your And candidly, we think this tactic reflects how concerned they are about our impending launch.”
Transcript header (unverified)
Biotechnology · Healthcare
